Targeting the adaptability of cancer cells is a promising area of research. Strategies include:
Combination Therapies: Using multiple drugs with different mechanisms of action can prevent cancer cells from easily developing resistance. Epigenetic Therapies: These aim to reverse epigenetic changes that enable cancer cell survival. Metabolic Inhibitors: Drugs that target specific metabolic pathways exploited by cancer cells can limit their adaptability. Immunotherapy: Enhancing the immune system's ability to recognize and destroy cancer cells can also counter their adaptive strategies.